Herceptin or trastuzumab, marketed by the pharmaceutical giant Roche, is a groundbreaking cancer drug. It is popularly used to treat patients suffering from both early-stage and metastatic (late-stage) HER2-positive breast cancer. As a revolutionary product from Roche, Herceptin has transformed the landscape of breast cancer treatment in the English-speaking world.